SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
SEC Accession No. 0001214659-21-001455
Filing Date
2021-02-09
Accepted
2021-02-09 08:30:27
Documents
4

Document Format Files

Seq Description Document Type Size
1 p28216dfan14a.htm DFAN14A 11820
2 EXHIBIT 99.1 ex99_1.htm EX-99.1 43926
3 GRAPHIC broadridge_logo.jpg GRAPHIC 8552
4 GRAPHIC img_02.gif GRAPHIC 109
  Complete submission text file 0001214659-21-001455.txt   69468
Mailing Address 4747 EXECUTIVE DRIVE SUITE 210 SAN DIEGO CA 92121
Business Address 4747 EXECUTIVE DRIVE SUITE 210 SAN DIEGO CA 92121 858-200-3830
TANG CAPITAL PARTNERS LP (Filed by) CIK: 0001191935 (see all company filings)

IRS No.: 680517277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DFAN14A

Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Subject) CIK: 0001671584 (see all company filings)

IRS No.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DFAN14A | Act: 34 | File No.: 001-37746 | Film No.: 21604019
SIC: 2834 Pharmaceutical Preparations